Overall market sentiment has been high on MannKind Corporation (MNKD) stock lately. MNKD receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With MNKD Stock Today?
MannKind Corporation (MNKD) stock is lower by -4.88% while the S&P 500 is up 0.27% as of 1:53 PM on Friday, Jun 25. MNKD is lower by -$0.23 from the previous closing price of $4.71 on volume of 2,686,123 shares. Over the past year the S&P 500 has risen 40.24% while MNKD is up 140.86%. MNKD lost -$0.27 per share in the over the last 12 months.
To screen for more stocks like MannKind Corporation click here.
More About MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Click Here to get the full Stock Score Report on MannKind Corporation (MNKD) Stock.
